- ►diabetesjournals.org A Maran, C Crepaldi, A Tiengo, G Grassi, E … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Both the insertion of the fiber and the wearing of the device were
well tolerated by the patients. Subcutaneous glucose levels were well correlated
with venous glucose measurements (r = 0.9, P < 0.001) over a wide range ... Cited by 136 - Related articles - BL Direct - All 6 versions
G Annuzzi, S Genovese, G Riccardi, M Previti, … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN — A multicenter study was performed in 70 diabetic patients. A
microdialysis fiber was inserted subcutaneously into the periumbelical region
and perfused with a buffer solution. Glucose concentrations in the ... Related articles
- ►diabetesjournals.org IM Wentholt, MA Vollebregt, AA Hart, JB … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Blood was sampled overnight twice per hour in 13
patients. Rapid-acting insulin was given subcutaneously 30 min after breakfast.
Sampling once per minute started 45 min after breakfast and 75 min after ... Cited by 39 - Related articles - BL Direct - All 5 versions
M Varalli, G Marelli, A Maran, S Bistoni, M … - Biosensors and Bioelectronics, 2003 - Elsevier The aim of this study was to evaluate the reproducibility, the accuracy and the
reliability of a continuous subcutaneous glucose measuring system. The
GlucoDay® system (A. Menarini IFRSrl—Florence, Italy) is a portable ... Cited by 20 - Related articles - All 4 versions
A Poscia, M Mascini, D Moscone, M Luzzana, G … - Biosensors and Bioelectronics, 2003 - Elsevier The performances and the stability of a novel subcutaneous glucose monitoring
system have been evaluated. GlucoDay® (A. Menarini IFRSrl, Florence Italy) is a
portable instrument provided with a micro-pump and a biosensor coupled to a ... Cited by 33 - Related articles - All 4 versions
B Feldman, R Brazg, S Schwartz, R Weinstein - Diabetes Technology & Therapeutics, 2003 - liebertonline.com Wired Enzyme™ (Therasense, Alameda, CA) sensing technology for continuous
measurement of in vivo glucose concentrations offers the benefits of (1)
excellent sensor stability, (2) re- duced susceptibility to variations of ... Cited by 71 - Related articles - BL Direct - All 3 versions
- Free from Publisher S Salardi, S Zucchini, R Santoni, L Ragni, S … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Of 44 pediatric patients with type 1 diabetes who
wore CGMS devices, 28 subjects were selected for the study. Criteria for
inclusion were high levels of HbA 1c (≥8%) for more than 1 year or a ... Cited by 62 - Related articles - BL Direct - All 7 versions
- ►up.pt [PDF] - Free from Publisher BP Kovatchev, LA Gonder-Frederick, DJ Cox, … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We approach the design of CG-EGA from the
understanding that continuous glucose sensors (CGSs) allow the observation of BG
fluctuations as a process in time. We account for specifics of process ... Cited by 85 - Related articles - BL Direct - All 7 versions
JJ Mastrototaro - Diabetes technology & therapeutics, 2000 - liebertonline.com D IABETES is a major source of morbidity, mortality, and economic expense. All
pa- tients with type 1 diabetes and an estimated 3–4 million patients in the
United States with type 2 diabetes must take insulin to control their glu- ... Cited by 279 - Related articles - BL Direct - All 5 versions
TM Gross, BW Bode, D Einhorn, DM Kayne, JH … - Diabetes Technology & Therapeutics, 2000 - liebertonline.com Page 1. DIABETES TECHNOLOGY & THERAPEUTICS Volume 2, Number 1, 2000 Mary Ann Liebert,
Inc. Performance Evaluation of the MiniMed ® Continuous ... Cited by 202 - Related articles - BL Direct - All 3 versions
